 |
|
The African Descent and Glaucoma Evaluation Study (ADAGES)Design and Baseline Data
Pamela A. Sample, PhD;
Christopher A. Girkin, MD, MSPH;
Linda M. Zangwill, PhD;
Sonia Jain, PhD;
Lyne Racette, PhD;
Lida M. Becerra, MS;
Robert N. Weinreb, MD;
Felipe A. Medeiros, MD;
M. Roy Wilson, MD;
Julio De León-Ortega, MD;
Celso Tello, MD;
Christopher Bowd, PhD;
Jeffrey M. Liebmann, MD; for the ADAGES Study Group
Arch Ophthalmol. 2009;127(9):1136-1145.
Objective To identify factors accounting for differences in glaucoma onset and rate of progression between individuals of African descent and European descent.
Design A prospective, multicenter observational cohort study of 1221 participants of African descent and European descent with no glaucoma (normal), suspected glaucoma, and glaucoma. Six hundred eighty-six patient participants in the African Descent and Glaucoma Evaluation Study will be followed up longitudinally. Four hundred thirty-six participants of European descent from the Diagnostic Innovations in Glaucoma Study (DIGS) were also included. Baseline demographics, visual function (standard automated perimetry, short-wavelength automated perimetry, frequency doubling technology perimetry), optic nerve structure (retina tomography, optical coherence tomography), clinical status, and risk factors were measured.
Results Individuals of African descent had (1) thinner corneas (P < .001) across all diagnostic groups, (2) a higher percentage of reported diabetes mellitus (P < .001) and high blood pressure (P < .001) and a lower percentage of reported heart disease (P = .001), and (3) worse pattern standard deviation for standard automated perimetry fields overall (P = .001) and within normal limits (P = .01) than individuals of European descent. No differences were present for mean intraocular pressure (P = .79).
Conclusions Significant baseline differences were found in a number of clinical findings between persons of African descent compared with European descent. Longitudinal data from the African Descent and Glaucoma Evaluation Study will be important for determining which baseline features are important and predictive for accurate diagnosis and follow-up in this high-risk group.
Trial Registration clinicaltrials.gov Identifier: NCT00221923.
Author Affiliations: Department of Ophthalmology and Hamilton Glaucoma Center (Drs Sample, Zangwill, Racette, Weinreb, Medeiros, and Bowd) and Division of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine (Dr Jain and Ms Becerra), University of California, San Diego, La Jolla; Department of Ophthalmology, School of Medicine, University of Alabama, Birmingham (Drs Girkin and De León-Ortega); University of Colorado, Denver (Dr Wilson); and New York Eye and Ear Infirmary, New York (Drs Tello and Liebmann).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Detection of retinal nerve fibre layer progression: comparison of the fast and extended modes of GDx guided progression analysis
Kjaergaard et al.
Br J Ophthalmol 2011;95:1707-1712.
ABSTRACT
| FULL TEXT
Combining Structural and Functional Measurements to Improve Detection of Glaucoma Progression using Bayesian Hierarchical Models
Medeiros et al.
IOVS 2011;52:5794-5803.
ABSTRACT
| FULL TEXT
A Comparison of Rates of Change in Neuroretinal Rim Area and Retinal Nerve Fiber Layer Thickness in Progressive Glaucoma
Alencar et al.
IOVS 2010;51:3531-3539.
ABSTRACT
| FULL TEXT
African Descent and Glaucoma Evaluation Study (ADAGES): II. Ancestry Differences in Optic Disc, Retinal Nerve Fiber Layer, and Macular Structure in Healthy Subjects
Girkin et al.
Arch Ophthalmol 2010;128:541-550.
ABSTRACT
| FULL TEXT
African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry Differences in Visual Function in Healthy Eyes
Racette et al.
Arch Ophthalmol 2010;128:551-559.
ABSTRACT
| FULL TEXT
|
